DOW JONES22,085.29+448.51 2.07%
S&P 5002,604.57+63.10 2.48%
NASDAQ7,710.73+208.35 2.78%

Stifel Initiates Coverage On Avadel Pharmaceuticals with Buy Rating, Announces $14 Price Target

Stifel analyst Paul Matteis initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and a $14 price target.

Benzinga · 03/12/2020 09:26

Stifel analyst Paul Matteis initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and a $14 price target.